Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2018 | Understanding how genetic mutations affect outcome in CLL

William Wierda • 12 Sep 2018
SOHO 2018
Chronic Lymphocytic Leukemia Leukemia

Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, William Wierda, MD, PhD, of the MD Anderson Cancer Center, Houston, TX, discusses his group’s 29-gene panel for genetically screening chronic lymphocytic leukemia (CLL) patients. He demonstrates how genetic data can be compared to treatment outcome, in order to illuminate the relationship between the CLL mutational landscape and treatment efficacy.

More from William Wierda

1:12
Primary analysis of TRANSCEND-CLL-004: liso-cel in R/R CLL
William Wierda • 10 Jun 2023
2:08
Disease characteristics impacting treatment decisions in CLL
William Wierda • 10 Jun 2023
2:20
Genomic evolution and resistance to pirtobrutinib in CLL: insights from the BRUIN study
William Wierda • 10 Jun 2023
1:07
The current status of liso-cel in CLL and updates from the TRANSCEND-CLL-004 trial
William Wierda • 28 Sep 2022

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals